162 related articles for article (PubMed ID: 7713164)
1. Putative cognition enhancers reverse kynurenic acid antagonism at hippocampal NMDA receptors.
Pittaluga A; Pattarini R; Raiteri M
Eur J Pharmacol; 1995 Jan; 272(2-3):203-9. PubMed ID: 7713164
[TBL] [Abstract][Full Text] [Related]
2. The "kynurenate test", a biochemical assay for putative cognition enhancers.
Pittaluga A; Vaccari D; Raiteri M
J Pharmacol Exp Ther; 1997 Oct; 283(1):82-90. PubMed ID: 9336311
[TBL] [Abstract][Full Text] [Related]
3. Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices.
Pittaluga A; Bonfanti A; Arvigo D; Raiteri M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):272-9. PubMed ID: 10344525
[TBL] [Abstract][Full Text] [Related]
4. Activity of putative cognition enhancers in kynurenate test performed with human neocortex slices.
Pittaluga A; Pattarini R; Andrioli GC; Viola C; Munari C; Raiteri M
J Pharmacol Exp Ther; 1999 Jul; 290(1):423-8. PubMed ID: 10381808
[TBL] [Abstract][Full Text] [Related]
5. GV 150526A, 7-Cl-kynurenic acid and HA 966 antagonize the glycine enhancement of N-methyl-D-aspartate-induced [3H]noradrenaline and [3H]dopamine release.
Mennini T; Mancini L; Reggiani A; Trist D
Eur J Pharmacol; 1997 Oct; 336(2-3):275-81. PubMed ID: 9384243
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 envelope protein gp120 potentiates NMDA-evoked noradrenaline release by a direct action at rat hippocampal and cortical noradrenergic nerve endings.
Pittaluga A; Raiteri M
Eur J Neurosci; 1994 Nov; 6(11):1743-9. PubMed ID: 7874313
[TBL] [Abstract][Full Text] [Related]
7. Effects of putative cognition enhancers on the NMDA receptor by [3H]MK801 binding.
Hamelin SM; Lehmann JC
Eur J Pharmacol; 1995 Aug; 281(3):R11-3. PubMed ID: 8521903
[TBL] [Abstract][Full Text] [Related]
8. Effect of 1-aminocyclopropanecarboxylic acid on N-methyl-D-aspartate-stimulated [3H]-noradrenaline release in rat hippocampal synaptosomes.
Clos MV; Garcia Sanz A; Trullas R; Badia A
Br J Pharmacol; 1996 Jun; 118(4):901-4. PubMed ID: 8799560
[TBL] [Abstract][Full Text] [Related]
9. Glycine stimulates [3H]noradrenaline release by activating a strychnine-sensitive receptor present in rat hippocampus.
Raiteri M; Fontana G; Fedele E
Eur J Pharmacol; 1990 Aug; 184(2-3):239-50. PubMed ID: 2150375
[TBL] [Abstract][Full Text] [Related]
10. Endogenous glycine modulates N-methyl-D-aspartate-evoked release of adenosine and [3H]noradrenaline from rat cortical slices.
Craig CG; White TD
Eur J Pharmacol; 1991 May; 197(1):1-7. PubMed ID: 1832638
[TBL] [Abstract][Full Text] [Related]
11. Effects of oxiracetam on neurotransmitter release from rat hippocampus slices and synaptosomes.
Raiteri M; Costa R; Marchi M
Neurosci Lett; 1992 Sep; 145(1):109-13. PubMed ID: 1361044
[TBL] [Abstract][Full Text] [Related]
12. Age-related decrease of the NMDA receptor-mediated noradrenaline release in rat hippocampus and partial restoration by D-cycloserine.
Pittaluga A; Fedele E; Risiglione C; Raiteri M
Eur J Pharmacol; 1993 Jan; 231(1):129-34. PubMed ID: 8444277
[TBL] [Abstract][Full Text] [Related]
13. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus.
Luccini E; Musante V; Neri E; Raiteri M; Pittaluga A
J Neurosci Res; 2007 Dec; 85(16):3657-65. PubMed ID: 17671992
[TBL] [Abstract][Full Text] [Related]
14. Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120.
Pittaluga A; Pattarini R; Severi P; Raiteri M
AIDS; 1996 May; 10(5):463-8. PubMed ID: 8724036
[TBL] [Abstract][Full Text] [Related]
15. Adaptive changes in the NMDA receptor complex in rat hippocampus after chronic treatment with CGP 39551.
Mennini T; Miari A; Presti ML; Rizzi M; Samanin R; Vezzani A
Eur J Pharmacol; 1994 Dec; 271(1):93-101. PubMed ID: 7698217
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel putative cognition enhancer mediating facilitation of glycine effect on strychnine-resistant sites coupled to NMDA receptor complex.
Lanza M; Bonnafous C; Colombo S; Revel L; Makovec F
Neuropharmacology; 1997 Aug; 36(8):1057-64. PubMed ID: 9294970
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of hippocampal neurones to kainic acid, and antagonism by kynurenate.
Stone TW
Br J Pharmacol; 1990 Dec; 101(4):847-52. PubMed ID: 1964821
[TBL] [Abstract][Full Text] [Related]
18. N-methyl-D-aspartate receptors mediating hippocampal noradrenaline and striatal dopamine release display differential sensitivity to quinolinic acid, the HIV-1 envelope protein gp120, external pH and protein kinase C inhibition.
Pittaluga A; Pattarini R; Feligioni M; Raiteri M
J Neurochem; 2001 Jan; 76(1):139-48. PubMed ID: 11145986
[TBL] [Abstract][Full Text] [Related]
19. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. III. Changes in the NMDA receptor complex induced by their functional cooperation.
Pittaluga A; Raiteri M
J Pharmacol Exp Ther; 1992 Oct; 263(1):327-33. PubMed ID: 1357159
[TBL] [Abstract][Full Text] [Related]
20. HA-966 acts at a modulatory glycine site to inhibit N-methyl-D-aspartate-evoked neurotransmitter release.
Keith RA; Mangano TJ; Meiners BA; Stumpo RJ; Klika AB; Patel J; Salama AI
Eur J Pharmacol; 1989 Aug; 166(3):393-400. PubMed ID: 2572428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
